Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Korean Scientist Faked Stem Cell Research

By Biotechdaily staff writers
Posted on 09 Jan 2006
Following an investigation, a panel at Seoul National University (Korea) has announced that Hwang Woo Suk, its leading scientist, falsified the results of his experiments to clone embryos and extract stem cells from them to match patients.

In an article in Science in June 2005, Dr. More...
Hwang claimed to have cloned human embryos by transferring the nucleus of an adult cell into an egg and then to have extracted stem cells from that egg that genetically matched patients, who would then be able to produce regenerated tissues that could treat their diseases.

Seoul University's Dean of Research Affairs, Dr. Roe Jung Hye, has reported that Dr. Hwang's team does not have scientific data to prove it has produced such stem cells. Furthermore, following extensive DNA testing, the investigative panel found that none of the stem cells created by Dr. Hwang were produced by cloning but were from fertilized eggs and were not designed specifically for patients. Now, the panel is also investigating a 2004 study by Dr. Hwang as well as his claim to have produced the first cloned dog. The panel is to announce it findings in mid-January, according to Dr. Roe.

In the meantime, Dr. Hwang has claimed that the authentic stem cells he developed were stolen from his lab, replaced by samples from MizMedi Hospital in Seoul, which participated in his research. However, he has resigned from the university and has apologized for the falsifications in his paper.

The episode has dashed the hopes of scientists worldwide who thought Dr. Hwang's work would be able to advance the technology for therapeutic cloning.



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.